Replies to post #141311 on PharmaCyte Biotech Inc (PMCB)

[livendi]

the only thing that would give pmcb a chance is an eu phase 1 trial and that they own 14.5 % of au. but with kw in charge i dont see it,look how woefully incomplete ind was to fda and thats after taking 4 yrs to submit,again fda trial is dead and u know it,the list is so long pmcb will never ever be able to complete,u all know this by the list from fda to lift the hold,if kw were gone and u got a real ceo to make sure ind submission for a phase 1 in eu could maybe be possible but again with kw in charge i dont see it,look at his resume,look at pmcb pps from 62 to 2 under kw and he was a defendent in 2 previous fraud cases,shares maxed out a 2.5 bill,its a shame the tech never got a chance to prove itself,bear was spot on when he said fda will never accept lohrs trials,they were way too long ago and cells have changed yet still kw went for a phase 2 and they knew it would be rejected hence the huge inside dump at submission,pmcb should have went for a phase 1 after fda meeting 4 yrs ago when the float was 750k but gain kw never does whats good for sh or company,its all about his crazy 100k a month salary and taking care of cronies,if he were gone maybe pmcb could go for a phase 1 in eu but not with kw still there,anyhow god bless everyone and good luck 2